Abstract 3262
Background
The characterization of adaptive immunity in the tumor microenvironment of non small cell lung cancer (NSCLC) is considered of outmost importance for the stratification of patients for immunotherapeutic approaches. For this, simple, feasible, inexpensive, reproducible and pathology based methodologies are needed, such as the evaluation of routine H&E stained slides, an approach that has been recently used for the interpretation of the immune-related pathologic response in the neoadjuvant immunotherapy setting.
Methods
We aimed to determine the prognostic significance of intratumoral and peritumoral tertiary lymphoid structures (TLS), plasma cells (PCs) and necrosis in a series of 140 patients with early stage, surgically resectable NSCLC. The evaluation of TLS (3-tiered score), PCs (4-tiered score) and necrosis (absent, focal, diffuse) was performed in hematoxylin-eosin (H&E) sections from surgical specimens of pulmonary wedge resection, lobectomy or pneumonectomy. Epidemiological data have been retrieved for 76 patients so far.
Results
In most of the tumors examined, presence of TLS and aggregates of PCs was noted (91% and 75%, respectively). The presence and density of TLS and PCs in the tumor microenvironment correlated with improved survival (p < 0.001 and p = 0.002 respectively, Kaplan-Meier). The presence of TLS also correlated positively with PC infiltrates (p < 0.001, CC = 0.644, Spearman). Importantly, all patients with diffuse large PCs aggregates (score 3) are alive for the follow-up period. On the contrary, the presence of diffuse necrosis proved to have an adverse effect on overall survival (p = 0.004, Kaplan-Meier) and showed no significant correlation with the presence of TLS and PCs.
Conclusions
The presence of elements of the adaptive immunity such as TLS and plasma cells is closely linked to clinical outcome in NSCLC. As plasma cell differentiation in the tumor environment correlated with the presence of TLS, this effector humoral immunity cell type might represent a surrogate marker of an effective immune response in the tumor microenvironment driven by the formation of Tertiary Lymphoid Structures.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
5011 - LCSCAF1 maintains cancer stem-like traits by stabilizing c-Myc protein and promotes metastasis and recurrence in lung cancer
Presenter: Tao Guo
Session: Poster Display session 1
Resources:
Abstract
4955 - XAF1 Enhances Temozolomide Induced Autophagic Cell Death through AMPK signaling pathway
Presenter: Mingoo Lee
Session: Poster Display session 1
Resources:
Abstract
5616 - The effect of cortisol on methylation patterns in breast cancer cell lines
Presenter: Haya Intabli
Session: Poster Display session 1
Resources:
Abstract
4649 - Global and sex-specific epigenome-wide association studies for the identification of the main methylated loci related to smoking in a Mediterranean population
Presenter: Judith Begona Ramirez Sabio
Session: Poster Display session 1
Resources:
Abstract
4984 - Whole transcriptomics analyses of mimicking Circulating Tumor Cells (CTCs) by single-cell RNA sequencing (scRNAseq)
Presenter: Jessica Garcia
Session: Poster Display session 1
Resources:
Abstract
5926 - Comparison of enzymatic- and bisulfite conversion to map the plasma cell-free methylome in cancer
Presenter: Nicole Lambert
Session: Poster Display session 1
Resources:
Abstract
5454 - Detection of low mutations in hepatocellular carcinoma by using circulating tumor DNA
Presenter: Esl Kim
Session: Poster Display session 1
Resources:
Abstract
4428 - Variants in the JAK1 and JAK2 genes in the risk and prognosis of patients with cutaneous melanoma
Presenter: Bruna Carvalho
Session: Poster Display session 1
Resources:
Abstract
4409 - P-Rex1 expression in breast cancer patients.
Presenter: Angela Lara Montero
Session: Poster Display session 1
Resources:
Abstract
4185 - Modulation of Risk of Cutaneous Melanoma Patients by Variants in STAT3 Gene and Functional Analysis
Presenter: Gabriela Gomez
Session: Poster Display session 1
Resources:
Abstract